基于IVUS研究载脂蛋白B、载脂蛋白A1及NHR、LMR与冠脉钙化程度的相关性
Research on the Correlations between Apolipoprotein B, Apolipoprotein A1, NHR, LMR and the Degree of Coronary Artery Calcification Based on IVUS
DOI: 10.12677/acm.2025.1582223, PDF,   
作者: 吴 琼:北华大学临床医学院,吉林 吉林;孙宓颖:北华大学附属医院心血管内科,吉林 吉林
关键词: 冠状动脉疾病(CAD)钙化斑块血管内超声(IVUS)载脂蛋白炎症指标Coronary Artery Disease (CAD) Calcified Plaque Intravascular Ultrasound (IVUS) Apolipoprotein Inflammatory Markers
摘要: 本综述探讨了载脂蛋白B (ApoB)、载脂蛋白A1 (ApoA1)、中性粒细胞与高密度脂蛋白比值(NHR)、淋巴细胞与单核细胞比值(LMR)与冠状动脉钙化斑块程度之间的关联。冠状动脉疾病(CAD)是全球主要的健康威胁,评估其严重性及钙化程度对疾病管理至关重要。传统的冠脉钙化评估方法存在一定的挑战,血管内超声(IVUS)技术作为一种先进的成像技术,具有提供更详细的冠脉钙化信息的优势。在心血管健康中,ApoB与ApoA1的比值作为一种生物标志物,显示出与冠脉疾病的密切关系,ApoB主要涉及脂质的转运和动脉粥样硬化的发生,而ApoA1则保护冠状动脉健康。新兴生物标志物如NHR和LMR也表现出用于炎症和免疫反应指示的潜力,其中NHR可反映炎症活动,而LMR则提供免疫功能的洞察。结合IVUS技术分析这些生物标志物数据,能够提供冠脉钙化与生物标志物之间的详细关系洞察,有助于优化冠心病的临床决策。对载脂蛋白和NHR、LMR进行综合分析显示,它们在冠脉钙化的临床评估中具有重要价值,并能显著影响临床决策。目前证实钙化与脂质沉积及炎症相关,因此基于IVUS,本文研究不同钙化指数组间载脂蛋B (apoprotein B, ApoB)、载脂蛋白A1 (apoprotein A1, ApoA1)及NHR、LMR与冠状动脉钙化(coronary artery calcification, CAC)程度的相关性,为CAC及其钙化程度的诊断、评估提供参考依据。
Abstract: This review explores the associations between apolipoprotein B (ApoB), apolipoprotein A1 (ApoA1), the ratio of neutrophils to high-density lipoprotein (NHR), and the ratio of lymphocytes to monocytes (LMR) and the severity of coronary artery calcification plaques. Coronary artery disease (CAD) is a major global health threat, and assessing its severity and calcification degree is crucial for disease management. Traditional methods for assessing coronary artery calcification have certain challenges. Intravascular ultrasound (IVUS) technology, as an advanced imaging technique, offers the advantage of providing more detailed information on coronary artery calcification. In cardiovascular health, the ratio of ApoB to ApoA1 serves as a biomarker and shows a close relationship with coronary artery disease. ApoB mainly involves lipid transport and the occurrence of atherosclerosis, while ApoA1 protects coronary artery health. Emerging biomarkers such as NHR and LMR also show potential for indicating inflammation and immune response, where NHR can reflect inflammatory activity, and LMR provides insights into immune function. Analyzing these biomarker data using IVUS technology can provide detailed insights into the relationship between coronary artery calcification and biomarkers, which is helpful for optimizing clinical decisions in coronary heart disease. A comprehensive analysis of apolipoproteins and NHR, LMR reveals their significant value in the clinical assessment of coronary artery calcification and can significantly influence clinical decisions. It has been confirmed that calcification is related to lipid deposition and inflammation. Therefore, based on IVUS, this study investigates the correlations between apolipoprotein B (ApoB), apolipoprotein A1, NHR, LMR, and the degree of coronary artery calcification (CAC) among different calcification index groups, providing a reference for the diagnosis and assessment of CAC and its calcification degree.
文章引用:吴琼, 孙宓颖. 基于IVUS研究载脂蛋白B、载脂蛋白A1及NHR、LMR与冠脉钙化程度的相关性[J]. 临床医学进展, 2025, 15(8): 219-225. https://doi.org/10.12677/acm.2025.1582223

参考文献

[1] Peng, J. and Li, J.J. (2021) Predicting Coronary Artery Calcification Using Traditional and Novel Lipid-Related Biomarkers in Untreated Patients with Angina-Like Chest Pain. Atherosclerosis, 331, e117. [Google Scholar] [CrossRef
[2] Shu, H., Han, S., Qiu, W., Li, J., Zhang, X., Su, H., et al. (2025) Association of the Monocyte to High-Density Lipoprotein Cholesterol Ratio and Neutrophil to High-Density Lipoprotein Cholesterol Ratio with the Severity of New-Onset Coronary Artery Disease. Journal of Inflammation Research, 18, 463-476. [Google Scholar] [CrossRef] [PubMed]
[3] Guo, J., Chen, M., Hong, Y., Huang, Y., Zhang, H., Zhou, Y., et al. (2023) Comparison of the Predicting Value of Neutrophil to High-Density Lipoprotein Cholesterol Ratio and Monocyte to High-Density Lipoprotein Cholesterol Ratio for In-Hospital Prognosis and Severe Coronary Artery Stenosis in Patients with ST-Segment Elevation Acute Myocardial Infarction Following Percutaneous Coronary Intervention: A Retrospective Study. Journal of Inflammation Research, 16, 4541-4557. [Google Scholar] [CrossRef] [PubMed]
[4] Okan, T. and Topaloglu, C. (2024) Association of Ratios of Monocyte/High-Density Lipoprotein Cholesterol and Neutrophil/High-Density Lipoprotein Cholesterol with Atherosclerotic Plaque Type on Coronary Computed Tomography. Cardio-Vascular Journal of Africa, 34, 1-6.
[5] Lee, J.W., Kim, J.Y., Han, K., Im, D.J., Lee, K.H., Kim, T.H., 马露. 冠状动脉造影和冠状动脉钙化评分在急性胸痛病人评估中的比较[J]. 国际医学放射学杂志, 2021, 44(6): 734.
[6] 张丽娟, 熊峰. 冠状动脉钙化的影像学评估及临床应用价值进展[J]. 心血管病学进展, 2019, 40(5): 789-792.
[7] Rahman, M.N., Nasir, A., Ullah, I., et al. (2023) Comparison of Clinical Outcomes of Calcified and Non-Calcified Coronary Artery Lesion Intervention under IVUS Guidance. Journal of the College of Physicians and Surgeons Pakistan, 33, 1355-1361. [Google Scholar] [CrossRef] [PubMed]
[8] Durhan, G., Hazirolan, T., Sunman, H., Karakaya, J., Karcaaltincaba, M., Aytemir, K., 谢胜男. 冠状动脉钙化评分与系统冠心病风险评分(SCORE)联合应用是否能更好地预测冠状动脉的明显狭窄: 与CT冠状动脉成像结果的相关性[J]. 国际医学放射学杂志, 2015, 38(3): 292.
[9] Mohamed, M., Bosserdt, M., Wieske, V., Dubourg, B., Alkadhi, H., Garciaet, M.J., 孔令红. CT血管成像与冠状动脉钙化评分相结合改善冠状动脉疾病诊断: 一项对接受有创冠状动脉成像的稳定型胸痛病人的协同Meta分析[J]. 国际医学放射学杂志, 2024, 47(3): 379.
[10] Doan, K., Liu, T., Yun, W., Kim, Y., Yun, K.H., Oh, S.K., et al. (2023) Intravascular Ultrasound Guided Intervention in Calcified Coronary Lesions Showed Good Clinical Outcomes during One Year Follow-Up. Journal of Clinical Medicine, 12, Article 4073. [Google Scholar] [CrossRef] [PubMed]
[11] Rakotoarison, O., Roleder, T., Zimoch, W., Kuliczkowski, W., Reczuch, K. and Kübler, P. (2024) Current Role of Intravascular Imaging in Percutaneous Treatment of Calcified Coronary Lesions. Advances in Clinical and Experimental Medicine, 33, 1277-1287. [Google Scholar] [CrossRef] [PubMed]
[12] Park, H., Kim, J.H., Hyun, J., Jeong, Y., Yang, Y., Choe, K., et al. (2019) TCT-358 Clinical Impact of Intravascular Ultrasound Guidance in Stenting for Angiographically Moderate-to-Severe Calcified Coronary Lesion. Journal of the American College of Cardiology, 74, B355. [Google Scholar] [CrossRef
[13] Budoff, M.J., Young, R., Lopez, V.A., Kronmal, R.A., Nasir, K., Blumenthal, R.S., et al. (2013) Progression of Coronary Calcium and Incident Coronary Heart Disease Events. Journal of the American College of Cardiology, 61, 1231-1239. [Google Scholar] [CrossRef] [PubMed]
[14] Borén, J., Packard, C.J. and Binder, C.J. (2025) Apolipoprotein B-Containing Lipoproteins in Atherogenesis. Nature Reviews Cardiology, 22, 399-413. [Google Scholar] [CrossRef] [PubMed]
[15] Ohwada, T., Sakamoto, T., Kanno, Y., Yokokawa, S., Amami, K., Nakazato, K., et al. (2019) Apolipoprotein B Correlates with Intra-Plaque Necrotic Core Volume in Stable Coronary Artery Disease. PLOS ONE, 14, e0212539. [Google Scholar] [CrossRef] [PubMed]
[16] Marchini, T., Hansen, S. and Wolf, D. (2021) ApoB-Specific CD4+ T Cells in Mouse and Human Atherosclerosis. Cells, 10, Article 446. [Google Scholar] [CrossRef] [PubMed]
[17] Taleb, A., Witztum, J.L. and Tsimikas, S. (2011) Oxidized Phospholipids on ApoB-100-Containing Lipoproteins: A Biomarker Predicting Cardiovascular Disease and Cardiovascular Events. Biomarkers in Medicine, 5, 673-694. [Google Scholar] [CrossRef] [PubMed]
[18] Singh, K. and Prabhakaran, D. (2024) Apolipoprotein B—An Ideal Biomarker for Atherosclerosis? Indian Heart Journal, 76, S121-S129. [Google Scholar] [CrossRef] [PubMed]
[19] Bilgic, S. and Sniderman, A.D. (2023) Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B for Cardiovascular Care. Current Opinion in Cardiology, 39, 49-53. [Google Scholar] [CrossRef] [PubMed]
[20] Ferin, R., Lima, A., Santos, E., Almeida, C., Pelicano, N., Martins, D., et al. (2014) Performance of Apo A-I and B, and Other Cardiovascular Risk Factors in Azorean Patients with Coronary Artery Disease—Preliminary Results. Atherosclerosis, 235, e294. [Google Scholar] [CrossRef
[21] Tewari, S., Singh, P. and Goel, P.K. (2018) Evaluation of β2 Microglobulin, Lipoprotein(α), APO A1 and APO B in Coronary Artery Disease Patients and Its Correlation with the Severity of Coronary Artery Disease. Heart, Lung and Circulation, 27, S28. [Google Scholar] [CrossRef
[22] Zhu, Y.M., Verma, S., Fung, M., McQueen, M.J., Anderson, T.J. and Lonn, E.M. (2017) Association of Apolipoproteins B and A-1 with Markers of Vascular Health or Cardiovascular Events. Canadian Journal of Cardiology, 33, 1305-1311.
[23] 王宏宇, 付茜, 苏福祥. 载脂蛋白B/载脂蛋白A1比值与急性冠脉综合征患者冠状动脉多支病变及斑块易损性的相关性[J]. 中国医科大学学报, 2022, 51(7): 577-582.
[24] 马培容. 载脂蛋白A1、B联合检测对冠心病患者诊断的价值[J]. 中华临床医师杂志: 电子版, 2016, 10(4): 156-157.
[25] 覃辉, 黄晓渝. 载脂蛋白B/载脂蛋白A1比值与缺血性卒中的相关性研究进展[J]. 中风与神经疾病杂志, 2024, 41(11): 1047-1050.
[26] 陈斌. 2型糖尿病合并冠心病患者apoB/apoAI比值与冠脉病变的相关性[J]. 安徽医药, 2016, 20(1): 74-77.
[27] 韩秀, 田雨灵, 卓小桢, 等. 载脂蛋白A、载脂蛋白B/载脂蛋白A比值与冠脉病变严重程度的相关性[J]. 西安交通大学学报(医学版), 2019, 40(2): 255-258.
[28] 王晓旭, 徐丹. apoB/apoA1比值与冠心病患者冠脉病变及预后相关性的研究[J]. 重庆医科大学学报, 2018, 43(8): 1041-1046.
[29] 涂光, 黄小密, 曾艳芳, 等. 中性粒细胞与高密度脂蛋白比值对冠状动脉慢血流的预测价值研究[J]. 实用心脑肺血管病杂志, 2023, 31(4): 50-53.
[30] 陈建林, 林泓, 方亦升, 等. 中性粒细胞与高密度脂蛋白胆固醇比值在心血管疾病中的应用[J]. 国际心血管病杂志, 2024, 51(6): 360-362, 366.
[31] 王祥桧, 葛文浪, 宋思凡, 等. 中性粒细胞与高密度脂蛋白胆固醇比值对急性心肌梗死病人院内主要心血管不良事件的预测价值[J]. 安徽医药, 2024, 28(7): 1333-1338.
[32] Gao, J., Lu, J., Sha, W., et al. (2022) Relationship between the Neutrophil to High-Density Lipoprotein Cholesterol Ratio and Severity of Coronary Artery Disease in Patients with Stable Coronary Artery Disease. Frontiers in Cardiovascular Medicine, 9, Article 1015398. [Google Scholar] [CrossRef] [PubMed]
[33] 涂光, 黄小密, 曾艳芳, 等. 中性粒细胞与高密度脂蛋白比值对冠状动脉慢血流的预测价值研究[J]. 实用心脑肺血管病杂志, 2023, 31(4): 50-53.
[34] 魏星, 张志鹏, 罗春苗. 中性粒细胞与高密度脂蛋白胆固醇比值和同型半胱氨酸对冠状动脉慢血流的预测价值[J]. 中国心血管病研究, 2023, 21(7): 626-631.
[35] Chuang, S., Liu, S., Chien, M., Lee, C., Lee, Y. and Chien, K. (2024) Neutrophil-to-High-Density Lipoprotein Ratio (NHR) and Neutrophil-to-Lymphocyte Ratio (NLR) as Prognostic Biomarkers for Incident Cardiovascular Disease and All-Cause Mortality: A Comparison Study. American Journal of Preventive Cardiology, 20, Article ID: 100869. [Google Scholar] [CrossRef] [PubMed]
[36] Kalyoncuoglu, M., Biter, H.İ., Ozturk, S., Belen, E. and Can, M.M. (2020) Predictive Accuracy of Lymphocyte-to-Monocyte Ratio and Monocyte-to-High-Density-Lipoprotein-Cholesterol Ratio in Determining the Slow Flow/No-Reflow Phenomenon in Patients with Non-ST-Elevated Myocardial Infarction. Coronary Artery Disease, 31, 518-526. [Google Scholar] [CrossRef] [PubMed]
[37] Vahit, D., Akboga, M.K., Samet, Y. and Hüseyin, E. (2017) Assessment of Monocyte to High Density Lipoprotein Cholesterol Ratio and Lymphocyte-to-Monocyte Ratio in Patients with Metabolic Syndrome. Biomarkers in Medicine, 11, 535-540. [Google Scholar] [CrossRef] [PubMed]
[38] Wu, J.C., Huang, D., Li, J.F., Yi, J.X., Lei, Y. and Yin, J. (2025) Predicting Cardiovascular Disease and All-Cause Mortality Using the lymphocyte-to-Monocyte Ratio: Insights from Explainable Machine Learning Models. International Journal of Cardiology Cardiovascular Risk and Prevention, 24, Article ID: 200372.
[39] Si, Y., Liu, J., Shan, W., Zhang, Y., Han, C., Wang, R., et al. (2020) Association of Lymphocyte-to-Monocyte Ratio with Total Coronary Plaque Burden in Patients with Coronary Artery Disease. Coronary Artery Disease, 31, 650-655. [Google Scholar] [CrossRef
[40] Oylumlu, M., Oylumlu, M., Arik, B., Demir, M., Ozbek, M., Arslan, B., et al. (2021) Monocyte to High‐Density Lipoprotein Cholesterol and Lymphocyte to Monocyte Ratios Are Predictors of In‐Hospital and Long‐Term Mortality in Patients with Acute Coronary Syndrome. International Journal of Clinical Practice, 75, e13973. [Google Scholar] [CrossRef] [PubMed]